BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld Science
  • BioWorld Asia
  • Data Snapshots
    • Biopharma
    • Medical technology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • NME Digest
  • Special reports
    • Infographics: Dynamic digital data analysis
    • BCI
    • Ebola outbreak
    • Hantavirus
    • Trump administration impacts
    • Med-tech outlook 2026
    • Under threat: mRNA vaccine research
    • BioWorld at 35
    • Biopharma M&A scorecard
    • Bioworld 2025 review
    • BioWorld MedTech 2025 review
    • BioWorld Science 2025 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Monday, August 3, 2026
Home » Authors » Lynn Yoffee

Lynn Yoffee

lynn.yoffee@clarivate.com
Articles

ARTICLES

Radioactive gold nanoparticles destroy prostate cancer tumors

April 21, 2010
By Lynn Yoffee

Stents for PAD with a new twist: vascular magnetic intervention

April 20, 2010
By Lynn Yoffee

FDA clears Cambridge Heart's test for sudden cardiac arrest

April 19, 2010
By Lynn Yoffee

Panasonic to sell hearing aids to U.S. golden boomer market

April 16, 2010
By Lynn Yoffee
Jan. 1, 2011 will mark the era of the golden boomers, when they officially start to retire. This massive generation is getting older and along with that comes the decline of health, which presents opportunities for many companies to target with new product offerings. Consumer electronics giant Panasonic (Osaka, Japan) sees just such an opportunity to be part of that golden age and has decided to enter the hearing care business in the U.S. market. (Medical Device Daily)
Read More

Headset allows anesthesiologists to stay focused on the patients

April 15, 2010
By Lynn Yoffee

Supramap to aid in war against stealthy, evolving pathogens

April 14, 2010
By Lynn Yoffee

Sanuwave's dermaPACE in pivotal trial for foot ulcers

April 9, 2010
By Lynn Yoffee
Rather than treating a wound, Sanuwave Health's (Alpharetta, Georgia) dermaPACE technology harnesses the power of regenerative medicine to stimulate the body's own biological healing mechanism. With enrollment just completed in a pivotal phase III trial of dermaPACE to treat diabetic foot ulcers, the company is closer to launching a product that could address a $2 billion market in the U.S. and an estimated $10 billion advanced wound care market globally. (Medical Device Daily)
Read More

Improved device permits rapid review of circulating tumor cells

April 7, 2010
By Lynn Yoffee

Deals roundup: CareFusion buys Medegen for $225 million in cash

April 6, 2010
By Lynn Yoffee

Urovalve's Surinate bladder device aims to improve quality of life

April 5, 2010
By Lynn Yoffee
View All Articles by Lynn Yoffee

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for Aug. 3, 2026.
  • Tuojie Biotech (Shanghai) synthesizes new SARM1 inhibitors

    BioWorld Science
    Tuojie Biotech (Shanghai) Co. Ltd. has prepared and tested NAD(+) hydrolase SARM1 (SAMD2; MyD88-5) inhibitors found to be potentially useful for the treatment of...
  • Silhouette illustration of DNA gene editing

    Death in Chinese gene-editing trial exposes ethical fault lines

    BioWorld
    The death of a 6-year-old girl after receiving an experimental brain-directed gene-editing therapy at the Xinhua Hospital in Shanghai has reopened debate over how...
  • Mitochondria

    Seed funding at Adjuvia to treat mitochondrial dysfunction

    BioWorld Science
    Adjuvia Therapeutics Inc. has closed a $8 million series seed financing round to advance its work developing therapeutics to treat mitochondrial dysfunction and...
  • Skin through magnifier

    Replimune’s RP-1 for melanoma wins over FDA adcom

    BioWorld
    Following two complete response letters in the past year, Replimune Group Inc.’s RP-1 (suvolimogene oderparepvec) for unresectable metastatic cutaneous melanoma...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Medical technology
    • Newco news
    • Opinion
    • Regulatory
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/metabolic
    • Immune
    • Infection
    • Neurology/psychiatric
    • NME Digest
    • Patents
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
    • Videos
Follow Us

Copyright ©2026. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing